
Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer
Keywords: دارودرمانی; prostatic neoplasms; drug therapy; prostatectomy; CALGB; Cancer and Leukemia Group B; CUOG; Canadian Urologic Oncology Group; ECOG; Eastern Cooperative Oncology Group; PSA; prostate specific antigen;